3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Breast Neoplasms
22
Neoplasm Metastasis
15
Carcinoma, Non-Small-Cell Lung
7
Glioblastoma
6
Colorectal Neoplasms
5
Triple Negative Breast Neoplasms
4
Recurrence
4
Ovarian Neoplasms
4
Lymphoma, Mantle-Cell
4
Lymphoma, Follicular
4
Endometrial Neoplasms
4
Brain Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Prostatic Neoplasms
3
Pancreatic Neoplasms
3
Neoplasms
3
Lymphoma, Large B-Cell, Diffuse
3
Lung Neoplasms
3
Hereditary Sensory and Autonomic Neuropathies
3
Head and Neck Neoplasms
3
Solid Tumors
2
Melanoma
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Esophageal Neoplasms
2
Waldenstrom Macroglobulinemia
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Treatment for Metastatic or Locally Advanced Cervical Cancer
1
Tongue Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
17
Iodine-131
16
lenvatinib
13
trametinib
12
Thyrotropin Alfa
11
Sorafenib
11
pembrolizumab
10
dabrafenib
10
Paclitaxel
9
vandetanib
8
Thyroxine
8
Surgical Procedures, Operative
7
Sunitinib
7
selpercatinib
6
cabozantinib
6
Nivolumab
6
Fluorodeoxyglucose F18
6
Everolimus
6
pazopanib
5
Vemurafenib
5
Thyroidectomy
5
Specimen Handling
5
Saline Solution
5
Radiotherapy
5
Radiofrequency Ablation
5
Cyclophosphamide
5
Cisplatin
5
Biopsy
5
apatinib
4
anlotinib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Thyroid Neoplasms
×
NVP-BKM120
×
Clear all
NCT01830504
2016-10-05
BKM120
Hospices Civils de Lyon
Phase 2
Unknown
47 enrolled